Pavlovskyi, L. “CERAMIDE AS A MARKER OF SEVERITY AND ACTIVITY OF DIABETES MELLITUS TYPE 2 AND NONALCOHOLIC FATTY LIVER DISEASE”. Biological Markers in Fundamental and Clinical Medicine (scientific journal) 2, no. 2 (November 15, 2018): 68-68. Accessed July 2, 2022. https://biologicalmarker.com/index.php/journal/article/view/137.